Dipna Pharmachem Limited

DPL

INE0MC401013

Specialty Chemicals

Market Closed - Bombay S.E. Other stock markets 06:00:58 2024-06-27 EDT			5-day change	1st Jan Change
7.99 ^INR	-0.25%		-3.73%	-24.98%

04-25	Dipna Pharmachem Limited announced a financing transaction	CI
04-02	Dipna Pharmachem Bags INR127.5 Million Order for Melamine Powder; Shares Jump 7%	MT

Dipna Pharmachem Limited Announces Resignation of Chinu Kalal from the Post of the Independent Director

January 31, 2023 at 08:44 am

Dipna Pharmachem Limited informed that Ms. Chinu Kalal, has resigned from the post of the Independent Director w.e.f. 31st January, 2023. Reason for Resignation: Due to my pre-occupation elsewhere.

Latest news about Dipna Pharmachem Limited

Dipna Pharmachem Limited announced a financing transaction	04-24	CI
Dipna Pharmachem Bags INR127.5 Million Order for Melamine Powder; Shares Jump 7%	04-02	MT
Dipna Pharmachem Limited Announces Resignation of Chinu Kalal as Non-Executive Independent Director	01-20	CI
Dipna Pharmachem Limited Announces Appointment of Madhuri Gurwani as Company Secretary and Compliance Officer	12-15	CI
Dipna Pharmachem Limited Reports Earnings Results for the Half Year Ended September 30, 2023	23-10-18	CI
200 Equity Shares of Dipna Pharmachem Limited are subject to a Lock-Up Agreement Ending on 20-SEP-2023.	23-09-19	CI
5,572,800 Equity Shares of Dipna Pharmachem Limited are subject to a Lock-Up Agreement Ending on 19-SEP-2023.	23-09-18	CI
Dipna Pharmachem Limited Announces Resignation of Ms. Khushboo Jethaliya as Company Secretary / Compliance Officer	23-08-21	CI
Dipna Pharmachem Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-10	CI
Dipna Pharmachem Limited Appoints Jitendra Parmar as Independent Director of the Company, with Effect from May 1, 2023	23-04-29	CI
Dipna Pharmachem Limited Announces Resignation of Chinu Kalal from the Post of the Independent Director	23-01-31	CI
Dipna Pharmachem Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-14	CI
Dipna Pharmachem Limited has filed an IPO in the amount of INR 152.076 million.	22-07-14	CI

Chart Dipna Pharmachem Limited

Duration

Period

More charts

Dipna Pharmachem Limited is an India-based trader, importer, and exporter in industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulation. The Company's products include albendazole, ambroxol HCL, amisulpride IP/BP, amoxicillin aripiprazole IP, artemether, azithromycin, cefixime, carbamezapin, calcium gluconate IP, cefadroxyl monohydrate IP/BP/EP cephalexin, clindamycin phosphate IP/BP/USP, clotrimazole, cetrimide powder, chlorhexidine base, chlorhexidine gluconate 20% solution, chlorhexidine hydrochloride, chlorhexidine acetate, dapoxetine HCL, dextromethorphan hydrobromic (DMR), diclofenac potassium, diclofenac sodium, dried alluminiumhydroxide IP, ferric ammounium citrate IP, ferrous ascorbate, folic acid IP, guaiphenesin IP, griseofulvin IP /BP, hydrocortisone acetate, ibuprofen IP, levofloxacin, lumefantrine, lidocaine base, lidocaine hydrochloride, lornoxicam, metronidazole plain/benzoate and mefenamic acid IP.

Sector

Specialty Chemicals

Calendar

2024-11-10 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Specialty Chemicals Wholesale

	1st Jan change	Capi.
DIPNA PHARMACHEM LIMITED	-24.98%	2.3M
REDOX LIMITED	+31.49%	1.05B
GHW INTERNATIONAL	+106.10%	216M
TOPCO TECHNOLOGIES CORP.	+9.93%	176M
GRATITUDE INFINITE	+26.71%	132M
HP ADHESIVES LIMITED	-3.81%	106M
SHANKAR LAL RAMPAL DYE-CHEM LIMITED	-0.65%	82.35M